When a group at Kyoto University and others analyzed documents explaining to patients about the treatment that administers cells that are being carried out at medical institutions nationwide for the purpose of cancer treatment and beauty, etc., the site and method of administration were written. It turned out that more than 40% of those who did not.
It is said that there is a possibility that treatments with suspected safety are being performed without sufficient explanation.
The research was conducted by a group led by Program-Specific Professor Misao Fujita of Kyoto University and published in the international scientific journal Cell Stem Cell.
Since cell administration to patients is also used in private clinics for cancer treatment and beauty care, the Act on Ensuring the Safety of Regenerative Medicine, etc. allows medical institutions to administer treatment plans that administer cells to patients. It will be submitted to the Ministry of Health, Labor and Welfare after being reviewed by a committee of experts.
The research group examined in detail 3467 documents explaining the content of treatment to patients included in the plans issued by approximately 2400 medical institutions by February 2018.
As a result, 1489 cases, or 43%, did not include basic safety information such as the site and method of cell administration.
It also includes treatments that international societies related to orthopedics and beauty have pointed out as ``insufficient scientific evidence,'' and treatments of doubtful safety and efficacy are being carried out without adequate explanations. I think there is a possibility.
Program-Specific Professor Fujita says, "We need a mechanism to clearly distinguish between treatments that are scientifically proven to be effective and safe, and those that are not."